Global enterprises eye China's growing healthcare market
With a sizable consumer base and a relentless drive for innovation, China's healthcare market has extended its allure to global enterprises, prompting many to expand their footprint, said a senior executive.
Vantive, a newly independent vital organ therapy company separated from US-Baxter, is enhancing innovation and digital healthcare in China as part of its long-term commitment to enabling longer, fuller lives for patients.
The company will step up efforts to collaborate with industry partners across the world to strengthen R&D capabilities that suit the local market and advance the development of kidney and vital organ therapies, said Chris Toth, CEO of Vantive.
"Vantive is focusing on building on our support of China's healthcare ecosystem, driving improved patient outcomes and supporting healthcare professionals in their essential work," Toth said. "We are strengthening our presence to enable patients and healthcare providers have access to critical kidney care and beyond."
With over 35 years in China, Vantive has operated three manufacturing facilities in Suzhou, Jiangsu province, Guangzhou, Guangdong province and Tianjin, as well as a world-class R&D center in Suzhou and a technical service center and headquarter in Shanghai.
As part of its deepening commitment, Vantive sees significant opportunities in developing digitally-enhanced solutions. Currently, the company's technology supports patients undergoing home dialysis, while its remote patient management platform leverages real-time data to streamline care processes.
"This remote patient management offers patients a familiar treatment environment, better quality of life, and continuous treatment during public health emergencies, while also relieving pressure on the healthcare system," Toth said.
"We will continue to focus on harnessing technology's potential to expand access to vital therapies, which are essential in delivering personalized, precise and efficient care tailored to the unique needs of patients in China," Toth said.
wangkeju@chinadaily.com.cn
